Home › Linfoma › Minnesota › Rochester
Studi clinici su Linfoma a Rochester, MN
11 studi su Linfoma cercano partecipanti presso sedi a Rochester e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
In reclutamentoFase 2
- Mayo Clinic in Rochester, Rochester
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
In reclutamentoFase 3
- Research Site, Rochester
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
In reclutamentoFase 1/2
- Mayo Clinic, Rochester
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
In reclutamentoFase 1/2
- Mayo Clinic, Clinical Trials Referral Office, Rochester
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
In reclutamentoFase 3
- Mayo Clinic Rochester, Rochester
DALY II USA/ MB-CART2019.1 for DLBCL
In reclutamentoFase 2
- Mayo Clinic, Rochester
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
In reclutamentoFase 1/2
- Mayo Clinic, Rochester
Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
In reclutamentoFase 1 inizialeVolontari sani benvenuti
- Mayo Clinic in Rochester, Rochester
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
In reclutamentoFase 2
- Mayo Clinic, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Mayo Clinic, Rochester
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
In reclutamento
- Mayo Clinic in Rochester, Rochester
Studi su Linfoma in altre città
- Houston, TX34 studi
- Boston, MA33 studi
- New York City, NY33 studi
- Washington, DC23 studi
- Baldwin Park, CA21 studi
- Chicago, IL20 studi
- Durham, NC17 studi
- St. Louis, MO15 studi
- Philadelphia, PA15 studi
- Cleveland, OH14 studi
- Edison, NJ12 studi
- Atlanta, GA12 studi
Altri studi a Rochester
- Cancro al seno42 studi
- Cancro del polmone non a piccole cellule37 studi
- Cancro metastatico31 studi
- Cancro (tutti i tipi)30 studi
- Cancro colorettale29 studi
- Cancro ovarico29 studi
- Mieloma multiplo24 studi
- Cancro alla prostata22 studi
- Insufficienza cardiaca22 studi
- Cancro pancreatico22 studi
- Cancro ai polmoni20 studi
- Cancro dell'endometrio20 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.